19
Actelion Pharmaceuticals Ltd, based in Switzerland, is a pharmaceutical company.
One of their notable products is EPOPROSTENOL SODIUM, with a corresponding application number 22260.
Regulatory Information RX
With a dosage strength EQ 1.5MG BASE/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 2008-06-27
Therapeutic Equivalence (TE) Code AP2
18
Actelion Pharmaceuticals Ltd, based in Switzerland, is a pharmaceutical company.
One of their notable products is EPOPROSTENOL SODIUM, with a corresponding application number 22260.
Regulatory Information RX
With a dosage strength EQ 0.5MG BASE/VIAL
Dosage Form Route INJECTABLE; INJECTION
Reference Listed Drug Yes
Approved since 2012-06-28
Therapeutic Equivalence (TE) Code AP2